DCIS Precision
  • Consortium
  • General Public
  • Scientific Community
  • Publications
  • Home
  • News
  • Contact
  • Clinical Trials
  • |
  • NL
Select Page

Low-Risk DCIS Research Update and Resources by PRECISION Patient Advocates

by MSdcisPrecision345af2af1 | Feb 2, 2023 | Home News Item #1, News

The PRECISION team is proud to share a document prepared by our wonderful team of Patient Advocates on the latest research and resources updates on Low-risk DCIS. The purpose of this document is to provide most up-to-date information about DCIS and its current...

Challenging the current dogma: DCIS – a precursor lesion, a risk lesion or both for subsequent invasive breast cancer?

by MSdcisPrecision345af2af1 | Jun 9, 2022 | Home News Item #2, News

Women with DCIS may develop invasive breast cancer in the same breast despite treatment. To study whether DCIS is the true precursor of all subsequent ipsilateral invasive breast cancer, PRECISION scientists compared the genetic changes in women with an initial DCIS...
PRECISION researcher wins prestigious Veni Grant awarded by the Dutch Research Council (NWO)

PRECISION researcher wins prestigious Veni Grant awarded by the Dutch Research Council (NWO)

by MSdcisPrecision345af2af1 | Nov 9, 2020 | News

Hendrik Messal, post doc in the lab of PRECISION Co-Investigator Jacco van Rheenen, has been awarded the prestigious Veni grant by the Dutch Research Council. He has been recognised for developing 3D whole organ microscopy with which he plans to investigate how...
Can invasive treatment be avoided for patients diagnosed with DCIS?

Can invasive treatment be avoided for patients diagnosed with DCIS?

by MSdcisPrecision345af2af1 | Oct 27, 2020 | News

Read an interview by CURE magazine featuring PRECISION’s patient advocate Donna Pinto and Co-Investigator Prof. Dr. Alastair Thompson. When patients with the earliest forms of breast cancer may be able to skip surgery

PRECISION launches a Series of Plain Language Summaries

by MSdcisPrecision345af2af1 | Oct 27, 2020 | News

The PRECISION patient advocates have launched a new and effective style of communicating our research to a wider audience including the public, policy makers and other relevant stakeholders. Read the plain language summary of the scientific publications and explore...
« Older Entries

More News

  • Low-Risk DCIS Research Update and Resources by PRECISION Patient Advocates
  • Challenging the current dogma: DCIS – a precursor lesion, a risk lesion or both for subsequent invasive breast cancer?
  • PRECISION researcher wins prestigious Veni Grant awarded by the Dutch Research Council (NWO)
  • Can invasive treatment be avoided for patients diagnosed with DCIS?
  • PRECISION launches a Series of Plain Language Summaries
  • PRECISION publishes its second newsletter
  • 5th World Congress on Controversies in Breast Cancer (CoBrCa 2019, San Francisco)
  • 2nd PRECISION Annual Meeting 13-14 June 2019
  • Feiten en Vragen LORD studie
  • PRECISION publishes it’s first newsletter
  • PRECISION publishes review article – Ductal carcinoma in situ: to treat or not to treat, that is the question
  • Becoming Professor…
  • ‘Over-diagnosis and over-treatment of breast cancer is a travesty in women’s healthcare’
  • PRECISION @ Association of Breast Surgery Conference 2019 – Future Management of DCIS
  • DCIS Dilemmas – clinician and patient advocate interactive session 13th June, NKI, Amsterdam
©2026 DCISprecision.org | Design by Mediaschip | FAQ | Cookie Policy